Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Res Commun Mol Pathol Pharmacol ; 115-116: 157-74, 2004.
Article in English | MEDLINE | ID: mdl-17564315

ABSTRACT

N-acetylation plays an important role in the metabolism of arylamine drugs and carcinogens and is catalyzed by cytosolic N-acetyltransferase (NAT). Gypenosides are the major components of Gynostemma pentaphyllum Makino which had been used as a natural folk medicine in the Chinese populations. Gypenosides were selected for examining the inhibition on the N-acetylation of 2-aminofluorene (AF), DNA-AF adduct formation and NAT gene expression in the human cervix epithelioid carcinoma cell line (HeLa). Various concentrations of gypenosides were individually added to the culture medium of human cervix epithelioid carcinoma cells (HeLa). The N-acetylation of AF was determined by high performance liquid chromatography (HPLC) assaying for the amounts of acetylated 2-aminofluorene (AAF) and nonacetylated 2-aminofluorene (AF). The N-acetylation of AF in the human HeLa cancer cells was suppressed by gypenosides in a dose-dependent manner. The data also demonstrated that gene expression (NAT1 mRNA) of NAT in human cervix epithelioid carcinoma cells (HeLa) was inhibited and decreased by gypenosides. After the incubation of HeLa cells with 30 or 60 microM AF and with or without 350 microg/ml gypenosides cotreatment, DNA was isolated and hydrolyzed to nucleotides, adducted nucleotides were extracted into butanol and analyzed DNA-AF adducts by HPLC. The data demonstrated that gypenosides decrease the levels of DNA-AF adduct formation in HeLa cells.


Subject(s)
Arylamine N-Acetyltransferase/metabolism , DNA Adducts/antagonists & inhibitors , Gene Expression/drug effects , Plant Extracts/toxicity , Acetylation/drug effects , Arylamine N-Acetyltransferase/genetics , Carcinogens/analysis , Carcinogens/metabolism , Chromatography, High Pressure Liquid , Culture Media/pharmacology , DNA Adducts/biosynthesis , Dose-Response Relationship, Drug , Fluorenes/analysis , Fluorenes/metabolism , Gynostemma/toxicity , HeLa Cells , Humans , RNA, Messenger/metabolism
2.
In Vivo ; 17(3): 281-8, 2003.
Article in English | MEDLINE | ID: mdl-12929581

ABSTRACT

The effects of gypenosides on the inhibition of N-acetyltransferase (NAT) activity, AF-DNA adduct formation and NAT gene expression in a human cervix cancer cell line (Ca Ski) were studied. Various concentrations of gypenosides were added to the cytosols or individually to the culture medium of human cervix cancer cells. The NAT activity was determined by high performance liquid chromatography, assaying for the amounts of acetylated 2-aminofluorene (AAF) and non-acetylated 2-aminofluorene (AF). The NAT activity in the human cervix intact cancer cells and cytosols was suppressed by gypenosides in a dose-dependent manner. The results also demonstrated that gene expression (NAT1 mRNA) in human cervix cancer cells was decreased by gypenosides in a dose-dependent manner. The apparent values of Km and Vmax of NAT of human cervix cancer cells were also decreased by gypenosides in cytosols. Gypenosides may act as noncompetitive inhibitors. After the incubation of human cervix cancer cells with 30 or 60 microM AF and with or without 350 micrograms/ml gypenosides co-treatment, the cells were recovered, DNA was prepared and hydrolyzed to nucleotides; adducted nucleotides were extracted in butanol and AF-DNA adducts were analyzed by HPLC. The results demonstrated that gypenosides decreased the levels of AF-DNA adduct formation in these cells. The NAT PCR and cDNA microarray also demonstrated that gypenosides inhibited NAT mRNA expression in human cervix cancer cells.


Subject(s)
Arylamine N-Acetyltransferase/metabolism , Carcinoma, Squamous Cell/enzymology , Fluorenes/pharmacokinetics , Gynostemma/toxicity , Plant Extracts/toxicity , Uterine Cervical Neoplasms/enzymology , Acetylation , Carcinogens/pharmacokinetics , Cell Line, Tumor , Female , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...